Evaldo dos Santos Monção Filho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Evaldo dos Santos Monção Filho has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Gerardo Magela Vieira Júnior
Universidade Federal do Piauí
3 shared publications - Mariana Helena Chaves
Departamento de Química, Universidade Federal do Piauí, Teresina 64049-550, Brazil
2 shared publications - Paulo Michel Pinheiro Ferreira
Federal University of Piaui
2 shared publications - Aline M. da Silva Duarte1 shared publication
- Alyne Rodrigues de Araújo
Universidade Federal do Delta do Parnaíba, Brasil
1 shared publication Ana Carolina Borges da Cruz Rodrigues
Laboratory of Tissue Engineering and Immunopharmacology, Oswaldo Cruz Foundation, 40296-710, Salvador, Brazil
1 shared publication
Latest Publications
- Open Access
- 15 June 2026
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 36 (1)
Rare Sesquiterpene from Leaves of Dipteryx lacunifera and Evaluation of Biological Activities
- 15 June 2026
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 36 (1)
Open AccessRare Sesquiterpene from Leaves of Dipteryx lacunifera and Evaluation of Biological Activities
- Open Access
- 11 July 2025
- Published by Wiley in Chemistry & Biodiversity
- Vol. 22 (11) , e01032
Antitumor and Cytogenotoxic Activities of Libidibia ferrea Hydroalcoholic Extracts in Murine Breast Carcinoma
Breast cancer is the most prevalent cancer type among women worldwide, and there is a critical need for more effective and safer treatments, especially for aggressive and therapy‐resistant subtypes. Libidibia ferrea , a native plant from Brazil, exhibits anti‐inflammatory, antimicrobial, antioxidant, and antitumor properties. This study evaluated the antioxidant activity and antitumor effects of hydroalcoholic extracts from the leaves (HAFL) and fruits (HAFR) of L. ferrea in murine breast carcinoma models. Chemical analysis revealed several phenolic compounds, including gallic and ellagic acids. HAFR showed three times more total phenolic content than HAFL and exhibited higher antioxidant, cytotoxic, and genotoxic activities, inducing DNA damage and cell death in MDA‐MB‐231 cells. In a 4T1 murine model, HAFR reduced tumor growth by 94% at doses of 0.3 and 3.0 g/kg without affecting body or liver weight. These findings suggest HAFR's potential as a therapeutic candidate for breast cancer treatment.
- 11 July 2025
- Published by Wiley in Chemistry & Biodiversity
- Vol. 22 (11) , e01032
Open AccessAntitumor and Cytogenotoxic Activities of Libidibia ferrea Hydroalcoholic Extracts in Murine Breast Carcinoma
Breast cancer is the most prevalent cancer type among women worldwide, and there is a critical need for more effective and safer treatments, especially for aggressive and therapy‐resistant subtypes. Libidibia ferrea , a native plant from Brazil, exhibits anti‐inflammatory, antimicrobial, antioxidant, and antitumor properties. This study evaluated the antioxidant activity and antitumor effects of hydroalcoholic extracts from the leaves (HAFL) and fruits (HAFR) of L. ferrea in murine breast carcinoma models. Chemical analysis revealed several phenolic compounds, including gallic and ellagic acids. HAFR showed three times more total phenolic content than HAFL and exhibited higher antioxidant, cytotoxic, and genotoxic activities, inducing DNA damage and cell death in MDA‐MB‐231 cells. In a 4T1 murine model, HAFR reduced tumor growth by 94% at doses of 0.3 and 3.0 g/kg without affecting body or liver weight. These findings suggest HAFR's potential as a therapeutic candidate for breast cancer treatment.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Journal of Venomous Animals and Toxins including Tropical Diseases
- Vol. 31, e20240064
Development and validation of a spectrophotometric method for the quantification of total bufadienolides in samples of toad glandular secretions
Background: Bufadienolides are the main secondary metabolites found in the paratoid gland secretions (PGS) of toads of the Bufonidae family. These compounds are considered the main bioactive components of PGS. The aim of this study was to develop and validate the first method for the quantification of total bufadienolides (free and esterified) in samples of paratoid secretions from toads, using the UV-Vis absorption spectrophotometry technique.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Journal of Venomous Animals and Toxins including Tropical Diseases
- Vol. 31, e20240064
Open AccessDevelopment and validation of a spectrophotometric method for the quantification of total bufadienolides in samples of toad glandular secretions
Background: Bufadienolides are the main secondary metabolites found in the paratoid gland secretions (PGS) of toads of the Bufonidae family. These compounds are considered the main bioactive components of PGS. The aim of this study was to develop and validate the first method for the quantification of total bufadienolides (free and esterified) in samples of paratoid secretions from toads, using the UV-Vis absorption spectrophotometry technique.
- 23 March 2023
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 310, 116406
Toxic profile of marinobufagin from poisonous Amazon toads and antitumoral effects on human colorectal carcinomas
- 23 March 2023
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 310, 116406
Toxic profile of marinobufagin from poisonous Amazon toads and antitumoral effects on human colorectal carcinomas